Precision-targeted therapy via antibody drugs has become central to the field of cancer immunotherapy. Monoclonal antibodies ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

In this video, Sham Mailankody, MBBS, discusses results from a first-in-human study of JNJ-5322, a next-generation trispecific antibody for treatment of patients with relapsed or refractory multiple ...